Makes automated microbial quality control systems for pharmaceutical manufacturing.
Jun 2026Revenue $35.2M/yrExpenses $84.9M/yr
No trendCash runway ≈ 6 months from Jun 2026
Figures by year
When will Rapid Micro Biosystems be profitable?
Its figures don’t show a steady enough trend to project a date. In the 12 months to Jun 2026, revenue was $35.2M and expenses $84.9M.
| Fiscal year to | Revenue | Expenses | Operating profit |
|---|---|---|---|
| Dec 2025 | $33.6M | $81.0M | −$47.4M |
| Dec 2024 | $28.1M | $78.0M | −$49.9M |
| Dec 2023 | $22.5M | $79.1M | −$56.6M |
| Dec 2022 | $17.1M | $80.4M | −$63.2M |
| Dec 2021 | $23.2M | $70.5M | −$47.2M |
| Dec 2020 | $16.1M | $46.6M | −$30.5M |
When the cash runs out, on the chart. A red line at the date the company’s cash would run out at its latest burn, so you can see whether it gets to break-even first. Part of a subscription.